Li Shuguang, Yin Yuyao, Chen Hongbin, Wang Qi, Wang Xiaojuan, Wang Hui
Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
Front Microbiol. 2017 Nov 9;8:2199. doi: 10.3389/fmicb.2017.02199. eCollection 2017.
Daptomycin-resistant (DAP-R) strains are well documented, but have not been reported in China. To elucidate the evolution adaptability and fitness cost of DAP-R , three DAP susceptible strains, Pre3 (MRSA, ST239-t037), Pre5 (MRSA, ST239-t037), and Pre14b (MSSA, ST188-t189), were isolated from patients with bloodstream infections, and serially passaged in Mueller-Hinton broth with a gradient of DAP concentration to select for resistance. Highly DAP-R mutants were obtained after screening for 34 passages. The DAP minimum inhibitory concentrations increased from 0.5 μg/ml in the parent strains to 16 μg/ml in the mutants, which remained tolerant to 4 μg/ml of DAP for more than 160 generations. The growth of the three mutant strains was slower than that of the parent strains, with relative fitness cost of 34.8%, 19.2%, and 15.0%, respectively. The serum tolerance of the mutants was decreased, and the lethality and pathogenicity in mice were weakened ( < 0.01). Transmission electron microscopy found that the cell walls of the mutants were significantly thicker (from 38.6% to 75.4%) than those of the parent cells. Mutation L826F of was found in Post14b, G299V, and L473I of and Y225N of were found in Post3, while T345A of , S52N of , and F473I of were found in Post5. Thus, stable DAP-R mutants could be obtained from a middle-short term of DAP selection, and according to their fitness cost, some prevention and control work may be done to cope with DAP-R that may appear in China in the future.
耐达托霉素(DAP-R)菌株已有充分记载,但在中国尚未见报道。为阐明DAP-R的进化适应性和适应性代价,从血流感染患者中分离出三株对DAP敏感的菌株Pre3(耐甲氧西林金黄色葡萄球菌,ST239-t037)、Pre5(耐甲氧西林金黄色葡萄球菌,ST239-t037)和Pre14b(甲氧西林敏感金黄色葡萄球菌,ST188-t189),并在含有不同浓度梯度DAP的 Mueller-Hinton肉汤中连续传代以筛选耐药性。经过34代筛选后获得了高度耐DAP的突变体。DAP的最低抑菌浓度从亲本菌株的0.5μg/ml增加到突变体中的16μg/ml,并且在超过160代的时间里对4μg/ml的DAP仍保持耐受。三株突变菌株的生长速度均比亲本菌株慢,相对适应性代价分别为34.8%、19.2%和15.0%。突变体的血清耐受性降低,在小鼠中的致死率和致病性减弱(P<0.01)。透射电子显微镜发现突变体的细胞壁比亲本细胞显著增厚(增厚38.6%至75.4%)。在Post14b中发现了rpoB基因的L826F突变,在Post3中发现了rpsL基因的G299V和L473I突变以及gyrA基因的Y225N突变,而在Post5中发现了rpoB基因的T345A突变、rpsL基因的S52N突变和gyrA基因的F473I突变。因此,通过短期至中期的DAP选择可获得稳定的DAP-R突变体,并根据其适应性代价,可开展一些防控工作以应对未来中国可能出现的DAP-R情况。